Ronald Zolty, M.D.
Dr. Ronald Zolty's current research involves clinical epidemiological studies looking at the different heart failure therapies stratified by ethnicity and etiology. He is also involved in numerous clinical research protocols in the field of pulmonary hypertension. He currently participates in several NIH funded grants and is a member of the Advisory Pulmonary Council of the International Society of Heart and Lung Transplant.
Dr. Zolty completed his medical education at the University of Geneva of Switzerland and his internal medicine residency at Hadassah University Hospital, Jerusalem and University Hospital of Geneva. He completed his fellowship in cardiology at the University of Colorado in Denver with a subspecialty in heart failure and cardiac transplantation. He then remained as faculty member at the University of Colorado Health Sciences Center before he moved to New York in 2006 to become director of the Heart Failure Program at Weiler. As part of the Heart Failure Program, he also developed a Pulmonary Hypertension Center.
While in Colorado, Dr. Zolty also received a PhD degree in Clinical Sciences. The theme of his thesis involved pharmacogenetic studies in heart failure patients treated with beta-blockade therapy.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.